In addition, a higher expression of the truncated ΔN isoform Δ133p53 of the TP53 gene detected in tumor tissues has been associated with worse outcomes in CCA patients [155], but no clinical correlation with drug response has been reported. Here, TP53 is linked to cholangiocarcinoma.